Skip to main content

The challenges of replicating the methodology between Phases I and III of the ISAAC programme

Buy Article:

$34.78 + tax (Refund Policy)

BACKGROUND: The International Study of Asthma and Allergies in Childhood (ISAAC) used standardised methods to examine symptom prevalence of asthma, rhinitis and eczema in adolescents and children between Phases I and III. Centres followed essential rules to ensure comparability of methodology, examined by a centralised data centre.

METHODS: Centre reports (CRs) were compared for both phases and age groups. Methodological differences were categorised under major deviations (centres excluded), minor deviations (deviations identified in published tables) and very minor deviations (deviations not identified).

RESULTS: There were 112 CRs for adolescents and 70 for children. Six centres for adolescents and four for children had major deviations and were excluded. Minor deviations (35 for adolescents and 20 for children) were identified in the publications. Very minor deviations (92 for adolescents and 51 for children) were not identified. The odds ratios for having any differences in methodology between phases with a change in Principal Investigator were 0.80 (95%CI 0.36–1.81) for adolescents and 0.91 (95%CI 0.32–2.62) for children.

CONCLUSION: The majority of the centres replicated the ISAAC methodology to a high standard. Careful documentation of methodology using standardised tools with careful checks allows the full potential of studies such as ISAAC to be realised.

Keywords: ISAAC; adolescents; children; methodology; replication

Document Type: Research Article

Affiliations: 1: Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand 2: School of Population Health, The University of Auckland, Auckland, New Zealand 3: International Union Against Tuberculosis and Lung Disease, Paris, France 4: Department of Paediatric Respiratory Medicine, Hospital Centro de Referencia de Salud El Pino, University of Santiago de Chile, Santiago, Chile 5: Division of Community Health Sciences, St George's, University of London, London, UK

Publication date: 01 May 2012

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content